Navigation Links
Low-cost sterilization method for cats and dogs is focus of new research project

WINSTON-SALEM, N.C. July 18, 2013 As an expert in molecular genetics, Colin E. Bishop, Ph.D.'s, usual role at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is to apply the techniques of genetics and developmental biology to the regeneration of human organs.

But, with a background specifically in reproductive genetics, Bishop is also on a mission to help solve the over-population of homeless dogs and cats. Bishop has been awarded a two-year pilot grant from Michelson Prize and Grants (MPG), a division of the Found Animals Foundation, to develop a one-shot, non-surgical method for sterilizing companion animals.

According to MPG, an estimated six million to eight million cats and dogs enter U.S. shelters and three to four million of these animals are euthanized. Bishop is one of about 20 grant recipients worldwide working on developing non-surgical, single dose sterilization technology. The foundation will award a $25 million prize to the first research entity to develop a successful product.

Bishop's approach is to develop an injection to destroy particular cells in the hypothalamus, an area in the brain about the size of a pearl that controls reproduction in mammals. Because brain cells do not regenerate, it is believed that the treatment will lead to permanent sterility in the animals. Just like neutering or spaying, this method has the potential to eliminate the unwanted mating behaviors of companion animals without affecting their general health.

Specifically, the treatment aims to destroy GnRH cells in the hypothalamus that stimulate hormones that control male and female fertility. Bishop is designing a novel system for delivering a toxin to the GnRH cells. He will engineer nano-sized packages called exosomes that are generated from adult stem cells. These packages will be tagged to carry the molecular "address" of the GnRH cells, so that other cell types will not be affected. Inside the package will be a deadly "message" a toxin derived from influenza-A that is designed to bind with and kill the GnRH cells.

The milestones of the two-year project include generating engineered exosomes from mouse stem cells and evaluating their potential to fuse with the GnRH cells. The team will then load the exosomes with the toxin and test their ability to kill GnRH cells in a laboratory setting and in mice.

The ultimate goal of MPG and the Found Animals Foundation is "to end shelter euthanasia of healthy, adoptable animals." According to the Found Animals website, a one-shot sterilization method could also be used internationally to reduce the population of homeless dogs and cats.


Contact: Karen Richardson
Wake Forest Baptist Medical Center

Related biology news :

1. Low-cost in-vitro fertilization method developed at CU may help couples in developing countries
2. Low-cost nano-biosensor to detect foodborne pathogen that causes listeriosis
3. Can algae-derived oils support large-scale, low-cost biofuels production?
4. Plants provide accurate low-cost alternative for diagnosis of West Nile Virus
5. Students create low-cost biosensor to detect contaminated water in developing nations
6. Low-cost carbon capture gets X-rayed
7. Low-cost nanosheet catalyst discovered to split hydrogen from water
8. Memorial Sloan-Kettering researchers develop new method for tracking cell signaling
9. Researchers create method to rapidly identify specific strains of illness
10. Gasification method turns forest residues to biofuel with less than a euro per liter
11. Gasification method turns forest residues to biofuel with less than a euro per litre
Post Your Comments:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology: